Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:1618-1624
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brevetti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brevetti, G.

European multicenter study on propionyl-L-carnitine in intermittent claudication

Gregorio Brevetti, MD*, Curt Diehm, MD{dagger}, David Lambert, MD{ddagger} on behalf of the Study Investigators

* Department of Medicine, University Federico II, Napoli, Italy
{dagger} Klinikum Karlsbad-Langensteinbach, Karlsbad-Langenfeld, Germany
{ddagger} Freeman Hospital, Newcastle-Upon Tyne, United Kingdom



View larger version (21K):

[in a new window]
 
Figure 1 Percent changes in ICD and MWD observed throughout the study in the S1 and S1 + S2 per-protocol population. (Dotted line) Changes in placebo group; (solid line) changes in propionyl-L-carnitine group.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement